Short- and long-term effects of furosemide on lung function in infants with bronchopulmonary dysplasia

The Journal of Pediatrics
|December 1, 1986
PubMed

Insights

Furosemide therapy can improve lung mechanics in infants with bronchopulmonary dysplasia (BPD). However, this diuretic treatment typically does not significantly improve gas exchange, indicating limited clinical benefit for respiratory support in BPD infants.

Area of Science:

  • Neonatal Medicine
  • Pediatric Pulmonology
  • Pharmacology

Background:

  • Bronchopulmonary dysplasia (BPD) is a chronic lung disease in infants.
  • Furosemide is a diuretic often used in BPD, but its impact on gas exchange is debated.
  • The relationship between improved lung mechanics and gas exchange in BPD infants treated with furosemide requires clarification.

Purpose of the Study:

  • To investigate the short- and long-term effects of furosemide on lung mechanics and gas exchange in infants with severe BPD.
  • To determine if improvements in lung mechanics correlate with improvements in gas exchange.

Main Methods:

  • 16 oxygen-dependent, hypercarbic infants with severe BPD were studied.
  • Measurements included transcutaneous PO2 and PCO2, esophageal pressure, airflow, and tidal volume.
  • Infants were assessed before, 1 hour after, and after 6-10 days of furosemide therapy; a control group was also monitored.

Main Results:

  • A single furosemide dose improved lung compliance.
  • Prolonged therapy improved compliance and resistance in the group.
  • Significant improvement in oxygenation occurred in only 6 of 16 infants; PCO2 was unaffected.
  • Changes in gas exchange did not correlate with changes in lung mechanics.

Conclusions:

  • Long-term furosemide therapy can enhance lung mechanical properties in infants with BPD.
  • Gas exchange, a critical measure of respiratory function, is generally not improved by furosemide.
  • The clinical significance of furosemide's effect on lung mechanics alone in BPD warrants further investigation.

Related Concept Videos

Breathing01:05

Breathing

The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Pulmonary Function Tests01:25

Pulmonary Function Tests

Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...